[Federal Register Volume 65, Number 163 (Tuesday, August 22, 2000)]
[Notices]
[Page 51008]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-21359]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Recombinant DNA Advisory Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Recombinant DNA Advisory Committee.
    Date: September 25-26, 2000.
    Time: 9 a.m. to 5 p.m.
    Agenda: Discussions of the report from the ACD Working Group on 
NIH Oversight of Clinical Gene Transfer Research; review of selected 
human gene transfer protocols; discussions of NIH policy on serious 
adverse event reporting; data management activities related to human 
gene transfer clinical trials, and other matters to be considered by 
the Committee. Additional information will be posted at http://www.nih.gov/od/oba/ on the internet.
    Place: National Institutes of Health, Building 31, C Wing, 
Conference Room 10, 9000 Rockville Pike, Bethesda, MD 20892.
    Contact Person: Eugene Rosenthal, Biotechnology Program Advisor, 
Office of Biotechnology Activities, National Institutes of Health, 
MSC 7010, 6000 Executive Boulevard, Suite 302, Bethesda, MD 20892-
7010, Telephone 301-496-9838, Fax 301-496-9839.


OMB's ``Mandatory Information Requirements for Federal Assistance 
Program Announcements'' (45 FR 39592, June 11, 1980) requires a 
statement concerning the official government programs contained in 
the Catalog of Federal Domestic Assistance. Normally NIH lists in 
its announcements the number and title of affected individual 
programs for the guidance of the public. Because the guidance in 
this notice covers virtually every NIH and Federal research program 
in which DNA recombinant molecule techniques could be used, it has 
been determined not to be cost effective or in the public interest 
to attempt to list these programs. Such a list would likely require 
several additional pages. In addition, NIH could not be certain that 
every Federal program would be included as many Federal agencies, as 
well as private organizations, both national and international, have 
elected to follow the NIH Guidelines. In lieu of the individual 
program listing, NIH invites readers to direct questions to the 
information address above about whether individual programs listed 
in the Catalog of Federal Domestic Assistance are affected.

    Dated: August 15, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-21359 Filed 8-21-00; 8:45 am]
BILLING CODE 4140-01-M